HL7 Terminology (THO), published by HL7 International - Vocabulary Work Group. This guide is not an authorized publication; it is the continuous build for version 7.4.11 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/UTG/ and changes regularly. See the Directory of published versions
: Detected Issue Clinical Impact
Raw ttl | Download
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
<http://hl7.org/fhir/CodeSystem/detectedissue-clinical-impact> a fhir:CodeSystem ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "detectedissue-clinical-impact"] ; #
fhir:language [ fhir:v "en"] ; #
fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem detectedissue-clinical-impact</b></p><a name=\"detectedissue-clinical-impact\"> </a><a name=\"hcdetectedissue-clinical-impact\"> </a><p>This case-sensitive code system <code>http://terminology.hl7.org/CodeSystem/detectedissue-clinical-impact</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">increased-effect<a name=\"detectedissue-clinical-impact-increased-effect\"> </a></td><td>Increased effect</td><td>The clinical or pharmacologic effect is expected to be increased for one or more implicated therapies.</td></tr><tr><td style=\"white-space:nowrap\">decreased-effect<a name=\"detectedissue-clinical-impact-decreased-effect\"> </a></td><td>Decreased effect</td><td>The clinical or pharmacologic effect is expected to be decreased for one or more implicated therapies.</td></tr><tr><td style=\"white-space:nowrap\">mixed-effect<a name=\"detectedissue-clinical-impact-mixed-effect\"> </a></td><td>Mixed effect</td><td>Mixed or differing changes in clinical or pharmacologic effects are expected.</td></tr><tr><td style=\"white-space:nowrap\">adverse-reaction<a name=\"detectedissue-clinical-impact-adverse-reaction\"> </a></td><td>Adverse reaction</td><td>An adverse reaction is expected or its risk is increased.</td></tr><tr><td style=\"white-space:nowrap\">additive-adverse-effects<a name=\"detectedissue-clinical-impact-additive-adverse-effects\"> </a></td><td>Additive adverse effects</td><td>Adverse or undesirable effects are expected to be additive for one or more implicated therapies.</td></tr><tr><td style=\"white-space:nowrap\">avoid-concurrent-use<a name=\"detectedissue-clinical-impact-avoid-concurrent-use\"> </a></td><td>Avoid concurrent use when possible</td><td>Concurrent use should generally be avoided because of the identified clinical risk.</td></tr><tr><td style=\"white-space:nowrap\">contraindicated-in-some-patients<a name=\"detectedissue-clinical-impact-contraindicated-in-some-patients\"> </a></td><td>Contraindicated in some patients</td><td>Concurrent use is contraindicated for a subset of patients based on patient-specific clinical characteristics or circumstances.</td></tr></table></div>"^^rdf:XMLLiteral ]
] ; #
fhir:extension ( [
fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg"^^xsd:anyURI ] ;
fhir:value [
a fhir:code ;
fhir:v "cds"
]
] [
fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status"^^xsd:anyURI ] ;
fhir:value [
a fhir:code ;
fhir:v "trial-use"
]
] [
fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm"^^xsd:anyURI ] ;
fhir:value [
a fhir:integer ;
fhir:v 3
]
] ) ; #
fhir:url [ fhir:v "http://terminology.hl7.org/CodeSystem/detectedissue-clinical-impact"^^xsd:anyURI] ; #
fhir:version [ fhir:v "1.0.0"] ; #
fhir:name [ fhir:v "DetectedIssueClinicalImpact"] ; #
fhir:title [ fhir:v "Detected Issue Clinical Impact"] ; #
fhir:status [ fhir:v "active"] ; #
fhir:experimental [ fhir:v false] ; #
fhir:date [ fhir:v "2026-09-14"^^xsd:date] ; #
fhir:publisher [ fhir:v "Health Level Seven International"] ; #
fhir:contact ( [
fhir:telecom ( [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "http://hl7.org" ]
] [
fhir:system [ fhir:v "email" ] ;
fhir:value [ fhir:v "hq@HL7.org" ]
] )
] ) ; #
fhir:description [ fhir:v "Codes that describe the potential clinical impact of a detected issue."] ; #
fhir:copyright [ fhir:v "This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license"] ; #
fhir:caseSensitive [ fhir:v true] ; #
fhir:valueSet [
fhir:v "http://terminology.hl7.org/ValueSet/detectedissue-clinical-impact"^^xsd:anyURI ;
fhir:link <http://terminology.hl7.org/ValueSet/detectedissue-clinical-impact>
] ; #
fhir:content [ fhir:v "complete"] ; #
fhir:concept ( [
fhir:code [ fhir:v "increased-effect" ] ;
fhir:display [ fhir:v "Increased effect" ] ;
fhir:definition [ fhir:v "The clinical or pharmacologic effect is expected to be increased for one or more implicated therapies." ]
] [
fhir:code [ fhir:v "decreased-effect" ] ;
fhir:display [ fhir:v "Decreased effect" ] ;
fhir:definition [ fhir:v "The clinical or pharmacologic effect is expected to be decreased for one or more implicated therapies." ]
] [
fhir:code [ fhir:v "mixed-effect" ] ;
fhir:display [ fhir:v "Mixed effect" ] ;
fhir:definition [ fhir:v "Mixed or differing changes in clinical or pharmacologic effects are expected." ]
] [
fhir:code [ fhir:v "adverse-reaction" ] ;
fhir:display [ fhir:v "Adverse reaction" ] ;
fhir:definition [ fhir:v "An adverse reaction is expected or its risk is increased." ]
] [
fhir:code [ fhir:v "additive-adverse-effects" ] ;
fhir:display [ fhir:v "Additive adverse effects" ] ;
fhir:definition [ fhir:v "Adverse or undesirable effects are expected to be additive for one or more implicated therapies." ]
] [
fhir:code [ fhir:v "avoid-concurrent-use" ] ;
fhir:display [ fhir:v "Avoid concurrent use when possible" ] ;
fhir:definition [ fhir:v "Concurrent use should generally be avoided because of the identified clinical risk." ]
] [
fhir:code [ fhir:v "contraindicated-in-some-patients" ] ;
fhir:display [ fhir:v "Contraindicated in some patients" ] ;
fhir:definition [ fhir:v "Concurrent use is contraindicated for a subset of patients based on patient-specific clinical characteristics or circumstances." ]
] ) . #
|
|
Propose a change